<?xml version="1.0" encoding="UTF-8"?>
<p id="p0125">The United Kingdom (UK) has a strong international reputation for scientific research and innovation, and a long history in vaccinology. Along with other countries, the UK Government mobilised resources to manage the Ebola outbreak, as well as played a role in testing Ebola vaccines in the UK, and West Africa. Alongside these efforts, the UK Chief Medical Officer for the Department of Health and Social Care (DHSC), Dame Sally Davies, raised the question to government and related stakeholders – 
 <italic>what could the UK do to be better prepared for future outbreaks of infectious diseases?</italic> A partnership was instigated across the DHSC, the UK Medical Research Council (MRC) and the Biotechnology and Biological Sciences Research Council (BBSRC), who then worked together to establish a ‘UK Vaccine Network’ (UKVN, 
 <ext-link ext-link-type="uri" xlink:href="http://www.gov.uk/government/groups/uk-vaccines-network" id="ir015" xmlns:xlink="http://www.w3.org/1999/xlink">www.gov.uk/government/groups/uk-vaccines-network</ext-link>) bringing together a small number of specialists from industry, academia and relevant funding bodies to make targeted investments in specific vaccines and vaccine technology for infectious diseases with the potential to cause an epidemic.
</p>
